{"id":11310,"date":"2022-07-01T20:32:33","date_gmt":"2022-07-02T00:32:33","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/immunotherapy-for-gynecologic-cancers\/"},"modified":"2022-07-14T15:59:36","modified_gmt":"2022-07-14T19:59:36","slug":"immunotherapy-for-gynecologic-cancers","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/immunotherapy-for-gynecologic-cancers","title":{"rendered":"Immunotherapy for Gynecologic Cancers"},"content":{"rendered":"<p style=\"text-align:center\"><iframe loading=\"lazy\" allowfullscreen=\"\" frameborder=\"0\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/f-Rq5mW-gVU\" width=\"640\"><\/iframe><\/p>\n<p>On June 4, 2013, Kunle Odunsi, MD, PhD, a specialist in immunotherapy for gynecologic cancers at Roswell Park Cancer Institute, discussed current immunotherapy treatment options for women with gynecologic cancers, and how close we are to making these treatments available to more patients, as part of the Cancer Research Institute&#39;s Breakthrough in Cancer Immunotherapy Webinar Series.<\/p>\n<p>Dr. Odunsi is chair of the Department of Gynecologic Oncology, and is a professor of oncology at Roswell Park Cancer Institute in Buffalo, NY. He is also the M. Steven Piver Endowed Professor of Gynecologic Oncology at Roswell Park, and professor of obstetrics and gynecology at the University of Buffalo. Dr. Odunsi also is the co-leader of the Tumor Immunology and Immunotherapy CCSG Program, and director of the Center for Immunotherapy at Roswell Park.<\/p>\n<p>Dr. Odunsi is a member of CRI\/Ludwig Cancer Vaccine Collaborative, a coordinated global network of clinical investigators with expertise in immunotherapy focused on optimizing the benefit patients can receive from immune-based cancer treatments.<\/p>\n<p>This webinar is part of the Cancer Research Institute&#39;s webinar series, &quot;Cancer Immunotherapy and You,&quot; which are offered free to the public and feature informative updates for patients and caregivers from leaders in cancer immunotherapy, followed by a Q&amp;A. This webinar was made possible with generous support from Dendreon. For more information on this webinar, or to register for upcoming webinars, please visit <a href=\"https:\/\/www.cancerresearch.org\/webinars\" target=\"_blank\" rel=\"noopener\">www.cancerresearch.org\/webinars<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Kunle Odunsi of Roswell Park Cancer Institute&nbsp;discusses&nbsp;current immunotherapy treatment options for women with gynecologic cancers, and how close we are to making these treatments available to more patients.<\/p>\n","protected":false},"featured_media":104,"template":"","events_categories":[198],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11310","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-webinars"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Immunotherapy for Gynecologic Cancers<\/title>\n<meta name=\"description\" content=\"Dr. Kunle Odunsi of Roswell Park Cancer Institute\u00a0discusses\u00a0current immunotherapy treatment options for women with gynecologic cancers.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunotherapy for Gynecologic Cancers\" \/>\n<meta property=\"og:description\" content=\"Dr. Kunle Odunsi of Roswell Park Cancer Institute\u00a0discusses\u00a0current immunotherapy treatment options for women with gynecologic cancers.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T19:59:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/a4ceabde-bc84-4733-a930-e6e8fb46115d.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Immunotherapy for Gynecologic Cancers\" \/>\n<meta name=\"twitter:description\" content=\"Dr. Kunle Odunsi of Roswell Park Cancer Institute\u00a0discusses\u00a0current immunotherapy treatment options for women with gynecologic cancers.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/a4ceabde-bc84-4733-a930-e6e8fb46115d.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers\",\"name\":\"Immunotherapy for Gynecologic Cancers\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0ddce7b6-2104-40db-a71f-9af56429ae64.jpg\",\"datePublished\":\"2022-07-02T00:32:33+00:00\",\"dateModified\":\"2022-07-14T19:59:36+00:00\",\"description\":\"Dr. Kunle Odunsi of Roswell Park Cancer Institute\u00a0discusses\u00a0current immunotherapy treatment options for women with gynecologic cancers.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0ddce7b6-2104-40db-a71f-9af56429ae64.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0ddce7b6-2104-40db-a71f-9af56429ae64.jpg\",\"width\":320,\"height\":208},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Immunotherapy for Gynecologic Cancers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immunotherapy for Gynecologic Cancers","description":"Dr. Kunle Odunsi of Roswell Park Cancer Institute\u00a0discusses\u00a0current immunotherapy treatment options for women with gynecologic cancers.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers","og_locale":"es_ES","og_type":"article","og_title":"Immunotherapy for Gynecologic Cancers","og_description":"Dr. Kunle Odunsi of Roswell Park Cancer Institute\u00a0discusses\u00a0current immunotherapy treatment options for women with gynecologic cancers.","og_url":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T19:59:36+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/a4ceabde-bc84-4733-a930-e6e8fb46115d.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"Immunotherapy for Gynecologic Cancers","twitter_description":"Dr. Kunle Odunsi of Roswell Park Cancer Institute\u00a0discusses\u00a0current immunotherapy treatment options for women with gynecologic cancers.","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/a4ceabde-bc84-4733-a930-e6e8fb46115d.jpg","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers","url":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers","name":"Immunotherapy for Gynecologic Cancers","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0ddce7b6-2104-40db-a71f-9af56429ae64.jpg","datePublished":"2022-07-02T00:32:33+00:00","dateModified":"2022-07-14T19:59:36+00:00","description":"Dr. Kunle Odunsi of Roswell Park Cancer Institute\u00a0discusses\u00a0current immunotherapy treatment options for women with gynecologic cancers.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0ddce7b6-2104-40db-a71f-9af56429ae64.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0ddce7b6-2104-40db-a71f-9af56429ae64.jpg","width":320,"height":208},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-for-gynecologic-cancers#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"Immunotherapy for Gynecologic Cancers"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11310","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/104"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11310"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11310"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11310"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11310"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11310"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11310"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}